C4 Therapeutics, Inc. (CCCC) Financials
CCCC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 328.9 million | 94.6 million |
| Dec. 31, 2025 | 359.1 million | 102.5 million |
| Sept. 30, 2025 | 265.5 million | 111.1 million |
| June 30, 2025 | 296.5 million | 122.5 million |
CCCC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -30.0 million | ? |
| Dec. 31, 2025 | -22.2 million | 4.0 million |
| Sept. 30, 2025 | -31.6 million | 4.6 million |
| June 30, 2025 | -12.2 million | 5.0 million |
CCCC Net Income
No data available :(
CCCC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 235.7 million | - | 51.9 million |
| Dec. 31, 2025 | 248.5 million | - | 53.6 million |
| Sept. 30, 2025 | 191.9 million | - | 61.5 million |
| June 30, 2025 | 214.6 million | - | 62.9 million |
CCCC Shares Outstanding
CCCC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 64000 | 24.6 million | 7.5 million | -1.8 million |
| Dec. 31, 2025 | 11000 | 25.0 million | 9.2 million | - |
| Sept. 30, 2025 | 411000 | 26.0 million | 8.9 million | - |
| June 30, 2025 | 185000 | 26.2 million | 8.8 million | - |
CCCC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 6.2 million | 1.8 million |
| Dec. 31, 2025 | 11.0 million | 1.8 million |
| Sept. 30, 2025 | 11.2 million | - |
| June 30, 2025 | 6.5 million | 2.1 million |
CCCC
Price: $3.96
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 914600
Market Capitalization: 357.1 million